A medical and scientific educational update on how genomic medicine is being used to deliver new therapies, reduce toxicity, enable early diagnosis and progress efforts to prevent cancer in children, teenagers and young adults.
Chaired by Professor Steve Clifford of Newcastle University and Dr Nick Goulden on behalf of Children with Cancer UK, key areas to be discussed in the meeting include:
Clinical Delivery Intiatives
100k genome GECIPS SMPaeds & INSTINCT Phase I/II networks
Speakers: Professors Steve Clifford, Adrienne Flannagan, Anthony Moorman, Darren Hargrave & Dr Lynley Marshall
Solid Tumour Biology Update
Brain Tumours, Neuroblastoma, Lymphoma
Speakers: Professor Chris Jones, Dr Sally George, Dr Simon Bomken
Immunotherapy and Tumour Microenvironment
CAR- T in Solid Tumours & Leukaemia, Senescence
Speakers: include Dr Karin Straathof and Dr Sara Ghorashian
Survivorship
QOL in Brain Tumours, Scope for prospective intervention
Speakers: include Dr Rod Skinner, Dr Sara Watts
Early Diagnosis and Screening
AML in Down syndrome , circulating DNA, NGS for detection of MRD
Speakers: include Dr John Moppett
Causation and Epidemiology
Update from Childhood Cancer 2018, Children with Cancer UK causation grant round
Speakers: Trustee Alasdair Philips, Professor Denis Henshaw
Genomic Medicine in Low- and Middle-Income Countries
Speakers: include Professor Simon Bailey, Dr Vikki Rand
Plenary lecture
Evolution of Cancer Genetics, Professor Christine Harrison Newcastle University
